全文获取类型
收费全文 | 15806篇 |
免费 | 904篇 |
国内免费 | 238篇 |
专业分类
耳鼻咽喉 | 99篇 |
儿科学 | 285篇 |
妇产科学 | 362篇 |
基础医学 | 2756篇 |
口腔科学 | 417篇 |
临床医学 | 799篇 |
内科学 | 3791篇 |
皮肤病学 | 515篇 |
神经病学 | 1023篇 |
特种医学 | 318篇 |
外国民族医学 | 1篇 |
外科学 | 2408篇 |
综合类 | 1054篇 |
现状与发展 | 1篇 |
预防医学 | 570篇 |
眼科学 | 408篇 |
药学 | 1170篇 |
3篇 | |
中国医学 | 283篇 |
肿瘤学 | 685篇 |
出版年
2023年 | 156篇 |
2022年 | 255篇 |
2021年 | 479篇 |
2020年 | 416篇 |
2019年 | 1483篇 |
2018年 | 1166篇 |
2017年 | 663篇 |
2016年 | 480篇 |
2015年 | 485篇 |
2014年 | 744篇 |
2013年 | 796篇 |
2012年 | 617篇 |
2011年 | 736篇 |
2010年 | 541篇 |
2009年 | 402篇 |
2008年 | 378篇 |
2007年 | 296篇 |
2006年 | 232篇 |
2005年 | 176篇 |
2004年 | 179篇 |
2003年 | 168篇 |
2002年 | 131篇 |
2001年 | 123篇 |
2000年 | 104篇 |
1999年 | 84篇 |
1998年 | 74篇 |
1997年 | 66篇 |
1996年 | 44篇 |
1995年 | 59篇 |
1994年 | 32篇 |
1993年 | 45篇 |
1992年 | 44篇 |
1991年 | 36篇 |
1990年 | 37篇 |
1988年 | 27篇 |
1987年 | 31篇 |
1986年 | 29篇 |
1985年 | 414篇 |
1984年 | 684篇 |
1983年 | 612篇 |
1982年 | 536篇 |
1981年 | 476篇 |
1980年 | 446篇 |
1979年 | 450篇 |
1978年 | 374篇 |
1977年 | 170篇 |
1976年 | 299篇 |
1975年 | 209篇 |
1974年 | 209篇 |
1973年 | 192篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Gut bacteria and gut barrier plays important roles in body homeostasis. Ciprofloxacin (CPFX) is widely used to treat bacterial infections. However, whether high dosage of CPFX has side effects on gut barrier integrity is still unclear. Our results indicated that the High CPFX treatment (1 mg/ml) caused weight loss, nervousness, anorexia, and increased apoptosis cells in gut, but less influence was observed in the Low CPFX group (0.2 mg/ml). Meanwhile, the High CPFX treatment impaired tight junction molecules Ocln/ZO-1 level and down-regulated antibacterial genes expression (reg3γ, pla2g2α and defb1). Further, the High CPFX treatment increased pro-inflammatory cytokine IL-1β in intestinal tract, decreased IL-17A of duodenum but increased IL-17A of colon at day 37. In addition, the gut bacterial diversity and richness behaved significantly loss regarding CPFX treatment, especially in the High CPFX group during the experiment. Indole exhibited sharply decline in both Low and High CPFX groups at day 7, and the High CPFX mice needed longer time on restoring indole level. Meanwhile, CPFX treatment strongly decreased the concentrations of butyric acid and valeric acid at day 1. Correlation analysis indicated that the linked patterns between the key bacteria (families Bacteroidales_S247, Ruminococcaceae and Desulfovibrionaceae) and metabolites (indole and butyric acid) were disturbed via the CPFX treatment. In conclusion, the High CPFX treatment impaired the gut barrier with the evidence of reduced expression of tight junction proteins, increased apoptosis cells and inflammatory cells, decreased the bacterial diversity and composition, which suggesting a proper antibiotic-dosage use should be carefully considered in disease treatment. 相似文献
3.
4.
5.
6.
目的比较骨填充网袋椎体成形术(Vesselplasty)与经皮椎体后凸成形术(percutaneous kyphoplasty,PKP)治疗 Kümmell 病的临床疗效。方法2015 年 1 月—2018 年 12 月收治 63 例 Kümmell 病患者,其中 28 例采用 Vesselplasty 治疗(Vesselplasty 组),35 例采用 PKP 治疗(PKP 组)。两组患者性别、年龄、病程、骨密度 T 值、骨折节段及术前疼痛视觉模拟评分(VAS)、Oswestry 功能障碍指数(ODI)、伤椎前缘高度、后凸 Cobb 角等一般资料比较,差异均无统计学意义(P>0.05),具有可比性。记录两组手术时间、术中透视时间、骨水泥注射量、骨水泥渗漏率、骨水泥弥散面积率和随访期间并发症发生情况,以及术前、术后 1 d、末次随访时 VAS 评分、ODI、伤椎前缘高度、后凸 Cobb 角。 结果两组患者均获随访,随访时间 12~36 个月,平均 24.2 个月。Vesselplasty 组手术时间、术中透视时间、骨水泥注射量、骨水泥弥散面积率均明显小于 PKP 组(P<0.05)。Vesselplasty 组骨水泥渗漏率(7.14%)明显低于 PKP 组(34.29%)(χ2=5.153,P=0.023)。两组患者术后 1 d 及末次随访时 VAS 评分、ODI、伤椎前缘高度、后凸 Cobb 角均较术前显著改善(P<0.05),术后两组间比较差异均无统计学意义(P>0.05)。随访期间两组均未见术椎再塌陷,Vesselplasty 组邻椎骨折发生率(7.14%)与 PKP 组(14.29%)比较,差异无统计学意义(χ2=0.243,P=0.622)。 结论Vesselplasty 和 PKP 治疗 Kümmell 病疗效相似,均能有效缓解患者疼痛症状,改善生活质量,部分恢复伤椎高度,矫正椎体后凸。但前者具有手术时间短、术中透视时间少、骨水泥渗漏少等优势。 相似文献
7.
Sania Amr Magdy Garas Dina N. K. Boulos Doa’a A. Saleh Irene A. Jillson Christopher A. Loffredo 《Journal of substance use》2019,24(3):341-345
Background: Egyptian street youth use substances including tobacco, illicit drugs, and pharmaceutical drugs. To understand the circumstances, including adverse childhood experiences, that place adolescents at risk for engaging in substance use, we conducted in-depth interviews among a sample of Egyptian street children. Methods: From youth residing at or attending Caritas, a non-profit organization, which provides shelter and education to street youth, seven girls and twelve boys, aged 12–18 years, participated in open-ended, in-depth interviews. Results: Eight out of the 19 participants reported family history (early exposure) to substance use; and seven of them were initiated by either a family member (sibling), friend or coworker. Most of the participants reported a history of conflict with or abuse (verbal or physical) by their parents or siblings, or stressful situations at home; they used substance(s) to alleviate their stress. Few attended school, and some were forced to work and help their family. Conclusions: Among Egyptian youth, adverse childhood experiences, such as poverty, child abuse, and family substance use, challenge somewhat susceptible youths and lead them to the path of substance use and addiction. Prevention intervention should be multifaceted, culturally adaptable, and primarily targeting the social environment during childhood. 相似文献
8.
Joseph F. Levy Rahul Khairnar Alexander V. Louie Timothy N. Showalter C. Daniel Mullins Mark V. Mishra 《Practical radiation oncology》2019,9(2):e172-e179
Purpose
A hydrogel rectal spacer (HRS) is a medical device that is approved by the U.S. Food and Drug Administration to increase the separation between the prostate and rectum. We conducted a cost-effectiveness analysis of HRS use for reduction in radiation therapy (RT) toxicities in patients with prostate cancer (PC) undergoing external beam RT (EBRT).Methods and Materials
A multistate Markov model was constructed from the U.S. payer perspective to examine the cost-effectiveness of HRS in men with localized PC receiving EBRT (EBRT alone vs EBRT + HRS). The subgroups analyzed included site of HRS placement (hospital outpatient, physician office, ambulatory surgery center) and proportion of patients with good baseline erectile function (EF). Data on EF, gastrointestinal and genitourinary toxicities incidence, and potential risks associated with HRS implantation were obtained from a recently published randomized clinical trial. Health utilities and costs were derived from the literature and the 2018 Physician Fee Schedule and were discounted 3% annually. Quality-adjusted life years (QALYs) and costs were modeled for a 5-year period from receipt of RT. Probabilistic sensitivity analysis and value-based threshold analyses were conducted.Results
The per-patient 5-year incremental cost for spacers administered in a hospital outpatient setting was $3578, and the incremental effectiveness was 0.0371 QALYs. The incremental cost-effectiveness ratio was $96,440/QALY for patients with PC undergoing HRS insertion in a hospital and $39,286/QALY for patients undergoing HRS insertion in an ambulatory facility. For men with good baseline EF, the incremental cost-effectiveness ratio was $35,548/QALY and $9627/QALY in hospital outpatient and ambulatory facility settings, respectively.Conclusions
Based on the current Medicare Physician Fee Schedule, HRS is cost-effective at a willingness to pay threshold of $100,000. These results contain substantial uncertainty, suggesting more evidence is needed to refine future decision-making. 相似文献9.
10.